Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
European Journal of Neurology|October 31, 2017
Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairmentJ Lee, S W Seo, J-J Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2019
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trialS T Kim, J H Kang, J Lee, et al.
European Journal of Neurology|August 13, 2015
Impact of smoking on neurodegeneration and cerebrovascular disease markers in cognitively normal menH Cho, C Kim, H J Kim, et al.
British Journal of Cancer|October 28, 2015
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancerS H Lim, T W Kim, Y S Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerS H Lim, J Y Lee, M-Y Lee, et al.
European Journal of Neurology|July 5, 2014
Higher C-peptide levels are associated with regional cortical thinning in 1093 cognitively normal subjectsC W Yoon, M Kang, H Y Shin, et al.
Oncogene|May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescenceJ-E Kim, J-S Shin, J-H Moon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung CancerM Altan, F Soto, T Xu, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Cell Death and Differentiation|October 22, 2013
p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTENS-W Hong, J-H Moon, J-S Kim, et al.
Pageof 23